<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04787523</url>
  </required_header>
  <id_info>
    <org_study_id>Rectrospect</org_study_id>
    <nct_id>NCT04787523</nct_id>
  </id_info>
  <brief_title>Rectrospect - a Retrospective Study of Treatment Response</brief_title>
  <acronym>Rectrospect</acronym>
  <official_title>Rectrospect - a Study on the Immun Cell Infiltrate in a Retrospective Rectal Cancer Cohort.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Biopisies from patients diagnosed with rectal cancer between 2007-2019 will be cut into 4-6&#xD;
      micrometer thin sections for morphology and immunostaining. Every section will be numbered&#xD;
      with a code that is connected to the patients personal identification number and the code&#xD;
      list will be kept separately from the biopsies in a password protected file on the&#xD;
      Sahlgrenska University Hospital server.&#xD;
&#xD;
      Patient data and outcome regarding response to treatment will be collected from patient&#xD;
      charts and the Swedish ColoRectal Cancer Registry, but all data will be numbered with the&#xD;
      same code number and all results will be kept away from the code list. In order to achieve&#xD;
      the stated aims, that is, to study how the molecular and cellular characteristics of the&#xD;
      tumour and its surrounding microenvironment as well as the interaction of tumour cells and&#xD;
      immune cells affect treatment response, several molecular and cellular techniques and assays&#xD;
      may be applied.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Immun cell infiltrate in pathology sections from the tumour</measure>
    <time_frame>Biopsies taken preoperatively</time_frame>
    <description>Number of of CD3+ and CD8+ cells in the tumour in relation to response to treatment</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">170</enrollment>
  <condition>Rectal Neoplasms</condition>
  <arm_group>
    <arm_group_label>Patients with pathological response to treatment</arm_group_label>
    <description>Response evaluated using the pathology report</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiotherapy</intervention_name>
    <description>Patients have received neoadjuvant radiotherapy</description>
    <arm_group_label>Patients with pathological response to treatment</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Biopsies taken at diagnosis&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated with neoadjuvant treatment between 2007-2019&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Rectal cancer and treatment between 2007 and 2019&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No rectal cancer or no neoadjuvant treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dept. of Surgery, Sahlgrenska University Hospital/Ostra</name>
      <address>
        <city>Gothenburg</city>
        <zip>SE 416 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 27, 2021</study_first_submitted>
  <study_first_submitted_qc>March 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2021</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Eva Angenete</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

